BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9334181)

  • 21. Identification of the human platelet GTPase activating protein for the CDC42Hs protein.
    Hart MJ; Shinjo K; Hall A; Evans T; Cerione RA
    J Biol Chem; 1991 Nov; 266(31):20840-8. PubMed ID: 1939135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Purification and characterization from rat liver cytosol of a GDP dissociation inhibitor (GDI) for liver 24K G, a ras p21-like GTP-binding protein, with properties similar to those of smg p25A GDI.
    Ueda T; Takeyama Y; Ohmori T; Ohyanagi H; Saitoh Y; Takai Y
    Biochemistry; 1991 Jan; 30(4):909-17. PubMed ID: 1899198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RhoGDI-binding-defective mutant of Cdc42Hs targets to membranes and activates filopodia formation but does not cycle with the cytosol of mammalian cells.
    Gibson RM; Wilson-Delfosse AL
    Biochem J; 2001 Oct; 359(Pt 2):285-94. PubMed ID: 11583574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of Rho protein binding to membranes by rhoGDI: inhibition of releasing activity by physiological ionic conditions.
    Bilodeau D; Lamy S; Desrosiers RR; Gingras D; BĂ©liveau R
    Biochem Cell Biol; 1999; 77(1):59-69. PubMed ID: 10426287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Consequences of weak interaction of rho GDI with the GTP-bound forms of rho p21 and rac p21.
    Sasaki T; Kato M; Takai Y
    J Biol Chem; 1993 Nov; 268(32):23959-63. PubMed ID: 8226937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Investigation of the GTP-binding/GTPase cycle of Cdc42Hs using fluorescence spectroscopy.
    Leonard DA; Evans T; Hart M; Cerione RA; Manor D
    Biochemistry; 1994 Oct; 33(40):12323-8. PubMed ID: 7918454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stimulation of phospholipase C-beta2 by the Rho GTPases Cdc42Hs and Rac1.
    Illenberger D; Schwald F; Pimmer D; Binder W; Maier G; Dietrich A; Gierschik P
    EMBO J; 1998 Nov; 17(21):6241-9. PubMed ID: 9799233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential properties of D4/LyGDI versus RhoGDI: phosphorylation and rho GTPase selectivity.
    Gorvel JP; Chang TC; Boretto J; Azuma T; Chavrier P
    FEBS Lett; 1998 Jan; 422(2):269-73. PubMed ID: 9490022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Solubilization of Cdc42Hs from membranes by Rho-GDP dissociation inhibitor.
    Leonard DA; Cerione RA
    Methods Enzymol; 1995; 256():98-105. PubMed ID: 7476460
    [No Abstract]   [Full Text] [Related]  

  • 30. RhoGDIgamma: a GDP-dissociation inhibitor for Rho proteins with preferential expression in brain and pancreas.
    Adra CN; Manor D; Ko JL; Zhu S; Horiuchi T; Van Aelst L; Cerione RA; Lim B
    Proc Natl Acad Sci U S A; 1997 Apr; 94(9):4279-84. PubMed ID: 9113980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ly-GDI, a GDP-dissociation inhibitor of the RhoA GTP-binding protein, is expressed preferentially in lymphocytes.
    Scherle P; Behrens T; Staudt LM
    Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7568-72. PubMed ID: 8356058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IQGAP1, a calmodulin-binding protein with a rasGAP-related domain, is a potential effector for cdc42Hs.
    Hart MJ; Callow MG; Souza B; Polakis P
    EMBO J; 1996 Jun; 15(12):2997-3005. PubMed ID: 8670801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maintenance of CDC42 GDP-bound state by Rho-GDI inhibits MAP kinase activation by the exchange factor Ras-GRF. evidence for Ras-GRF function being inhibited by Cdc42-GDP but unaffected by CDC42-GTP.
    Arozarena I; Matallanas D; Crespo P
    J Biol Chem; 2001 Jun; 276(24):21878-84. PubMed ID: 11285260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular cloning and characterization of yeast rho GDP dissociation inhibitor.
    Masuda T; Tanaka K; Nonaka H; Yamochi W; Maeda A; Takai Y
    J Biol Chem; 1994 Aug; 269(31):19713-8. PubMed ID: 8051050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kinetics of Cdc42 membrane extraction by Rho-GDI monitored by real-time fluorescence resonance energy transfer.
    Nomanbhoy TK; Erickson JW; Cerione RA
    Biochemistry; 1999 Feb; 38(6):1744-50. PubMed ID: 10026253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Catalysis of guanine nucleotide exchange on the CDC42Hs protein by the dbl oncogene product.
    Hart MJ; Eva A; Evans T; Aaronson SA; Cerione RA
    Nature; 1991 Nov; 354(6351):311-4. PubMed ID: 1956381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure of the Rho family GTP-binding protein Cdc42 in complex with the multifunctional regulator RhoGDI.
    Hoffman GR; Nassar N; Cerione RA
    Cell; 2000 Feb; 100(3):345-56. PubMed ID: 10676816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How RhoGDI binds Rho.
    Longenecker K; Read P; Derewenda U; Dauter Z; Liu X; Garrard S; Walker L; Somlyo AV; Nakamoto RK; Somlyo AP; Derewenda ZS
    Acta Crystallogr D Biol Crystallogr; 1999 Sep; 55(Pt 9):1503-15. PubMed ID: 10489445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fluoride activation of the Rho family GTP-binding protein Cdc42Hs.
    Hoffman GR; Nassar N; Oswald RE; Cerione RA
    J Biol Chem; 1998 Feb; 273(8):4392-9. PubMed ID: 9468490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A non-receptor tyrosine kinase that inhibits the GTPase activity of p21cdc42.
    Manser E; Leung T; Salihuddin H; Tan L; Lim L
    Nature; 1993 May; 363(6427):364-7. PubMed ID: 8497321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.